Abvc Biopharma ABVC
NASDAQ ABVC
$1.02 -0.04 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Operating Expenses (2010 - 2026)

Updated

Abvc Biopharma's Operating Expenses came in at $779,526 for Q2 2026, down 66.0% from $2.29 million a year earlier and down 50.4% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Operating Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Abvc Biopharma reported Operating Expenses of $6.52 million, up 48.6% year-over-year; for FY2025, it was $7.15 million, up 37.2% from FY2024.

  • Operating Expenses carries a five-year compound annual growth rate of -4.4% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $5.21 million in FY2024 (-21.2%), $6.62 million in FY2023 (-58.1%), $15.8 million in FY2022 (+31.0%) and $12.06 million in FY2021 (+34.4%).
  • The Q2 2026 figure represents the lowest quarterly Operating Expenses since Q1 2025.
  • Year-over-year, Operating Expenses increased in five of the last eight quarters, with growth averaging 67.0%.
  • The fastest year-over-year change in Operating Expenses over five years came in Q1 2022 (growth of 312.1%), and the weakest in Q4 2023 (a decline of 89.2%).
  • Business Quant data shows ABVC's Operating Expenses at $1.57 million (Q1 2026), $2.2 million (Q4 2025) and $1.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Abvc Biopharma 27.31 Mn 29.30 Mn - 779,526.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 779,526.00
Mar 31, 2026 1.57 Mn
Dec 31, 2025 2.20 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 2.29 Mn
Mar 31, 2025 693,005.00
Dec 31, 2024 706,530.00
Sep 30, 2024 691,296.00
Jun 30, 2024 977,059.00
Mar 31, 2024 2.84 Mn
Dec 31, 2023 374,794.00
Sep 30, 2023 2.14 Mn
Jun 30, 2023 2.13 Mn
Mar 31, 2023 1.97 Mn
Dec 31, 2022 3.46 Mn
Sep 30, 2022 3.75 Mn
Jun 30, 2022 2.35 Mn
Mar 31, 2022 6.24 Mn
Dec 31, 2021 6.41 Mn
Sep 30, 2021 2.07 Mn
API Access

Abvc Biopharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY